1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. IGEA Pharma N.V.
  6. News
  7. Sector news
    IGPH   NL0012768675

IGEA PHARMA N.V.

(IGPH)
  Report
Delayed Swiss Exchange  -  03:12 2022-07-05 am EDT
0.1000 CHF   -7.83%
06/26IGEA PHARMA N : Notice to postpone annual general meeting IGEA Pharma N.V.
PU
06/15IGEA PHARMA N : Note of the Board
PU
06/15IGEA PHARMA N.V. : IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Sector news Diagnostic & Testing Substances
07/01Agnelli's Exor expands in healthcare with 10% stake in Institut Merieux
RE
07/01Agnelli's Exor to invest 833 million euros for 10% stake in France's Institut Merieux
RE
06/2410X GENOMICS, INC.(NASDAQGS : TXG) added to Russell Small Cap Comp Value Index
CI
06/2410X GENOMICS, INC.(NASDAQGS : TXG) added to Russell 3000E Value Index
CI
06/2410X GENOMICS, INC.(NASDAQGS : TXG) added to Russell Midcap Value Index
CI
06/2410X GENOMICS, INC.(NASDAQGS : TXG) added to Russell 2500 Value Index
CI
06/2410X GENOMICS, INC.(NASDAQGS : TXG) added to Russell 1000 Value Index
CI
06/2410X GENOMICS, INC.(NASDAQGS : TXG) added to Russell 3000 Value Index
CI
06/20AUTOBIO DIAGNOSTICS CO., LTD.(XSSC : 603658) dropped from S&P Global BMI Index
CI
06/17Shenzhen New Industries Biomedical Engineering Co., Ltd. Implements Final Cash Dividend..
CI
06/13AUTOBIO DIAGNOSTICS CO., LTD.(XSSC : 603658) dropped from FTSE All-World Index
CI
06/10AUTOBIO DIAGNOSTICS CO., LTD.(SHSE : 603658) dropped from Shanghai Stock Exchange 180 Valu..
CI
06/10AUTOBIO DIAGNOSTICS CO., LTD.(SHSE : 603658) dropped from SSE 180 Index
CI
06/0710x Genomics Inc. Advances Leadership and Innovation in Single Cell and Spatial Technol..
CI
05/24BioMérieux Receives Health Canada Approval for BIOFIRE® Blood Culture Identification 2 ..
CI
05/19BioMérieux Closes Purchase Of US-based Biotechnology Group Specific Diagnostics
MT
05/19BioMérieux S.A. completed the acquisition of remaining unknown shares in Specific Diagn..
CI
05/13Shenzhen New Industries Biomedical Engineering Co., Ltd. Approves Cash Dividend for 202..
CI
05/13BioMérieux Receives CE Marking For Automated Chikungunya Virus Tests
MT
05/10TRANSCRIPT : 10x Genomics, Inc. Presents at Bank of America 2022 Healthcare Conference, Ma..
CI
05/06TRANSCRIPT : DiaSorin S.p.A., Q1 2022 Earnings Call, May 06, 2022
CI
05/06DiaSorin S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/05Citigroup Adjusts 10x Genomics' Price Target to $100 from $150, Keeps Buy Rating
MT
05/04Earnings Flash (TXG) 10X GENOMICS Posts Q1 Loss $-0.38, vs. Street Est of $-0.34
MT
05/04Earnings Flash (TXG) 10X GENOMICS Posts Q1 Revenue $114.5M, vs. Street Est of $113.3M
MT
05/04TRANSCRIPT : 10x Genomics, Inc., Q1 2022 Earnings Call, May 04, 2022
CI
05/0410x Genomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/0410x Genomics, Inc. Maintains Revenue Guidance for Full Year 2022
CI
05/04France's BioMérieux Wins US FDA Approval for Joint Infection Testing Panel
MT
04/27TRANSCRIPT : BioMérieux S.A., Q1 2022 Earnings Call, Apr 27, 2022
CI
04/26Autobio Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended Marc..
CI
04/22Shenzhen New Industries Biomedical Engineering Co., Ltd. Announces Profit Distribution ..
CI
04/21Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for t..
CI
04/1410x Genomics Launches Fixed RNA Profiling, Nuclei Isolation Kits; Shares Drop
MT
04/1410x Genomics Launches Two New Products to Unlock Wider Range of Samples for Single Cell..
CI
04/13Goldman Sachs Adjusts 10x Genomics' Price Target to $85 from $95, Keeps Neutral Rating
MT
04/12TRANSCRIPT : BioMérieux S.A., Q1 2022 Sales/ Trading Statement Call, Apr 12, 2022
CI
04/12France's BioMérieux To Buy US Biotechnology Group Specific Diagnostics
MT
04/12BioMérieux S.A. entered into an agreement to acquire remaining unknown shares in Specif..
CI
04/11BioMérieux S.A. Reports Sales Results for the Three Months Ended March 31, 2022
CI
04/02Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on Marc..
CI
03/19Autobio Diagnostics Co., Ltd. announces an Equity Buyback for CNY 300 million worth of ..
CI
03/18BioMérieux's Mass Spectrometry Identification System Wins US FDA Clearance
MT
03/18Autobio Diagnostics Co., Ltd. authorizes a Buyback Plan.
CI
03/16TRANSCRIPT : 10x Genomics, Inc. - Special Call
CI
03/16DiaSorin S.p.A. Proposes Dividend for the Year 2021
CI
03/16DiaSorin S.p.A. Provides Revenue Guidance for the Year 2022
CI
03/16TRANSCRIPT : DiaSorin S.p.A., 2021 Earnings Call, Mar 16, 2022
CI
03/16DiaSorin S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
03/07TRANSCRIPT : 10x Genomics, Inc. Presents at 42nd Annual Cowen Health Care Conference, Mar-..
CI
1  2  3  4  5  6  7  8  9  10Next